| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BJC.1992.418 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1978026 |
| https://europepmc.org/articles/PMC1978026?pdf=render | ||
| https://www.nature.com/articles/bjc1992418.pdf | ||
| http://www.nature.com/articles/bjc1992418 | ||
| http://www.nature.com/articles/bjc1992418.pdf | ||
| P932 | PMC publication ID | 1978026 |
| P698 | PubMed publication ID | 1280990 |
| P5875 | ResearchGate publication ID | 21874694 |
| P2093 | author name string | L. I. Wiebe | |
| A. J. Franko | |||
| M. B. Parliament | |||
| P2860 | cites work | The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. | Q33471029 |
| Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor | Q33840709 | ||
| The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo | Q33850001 | ||
| NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole | Q35981697 | ||
| Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study | Q35992946 | ||
| A marker for hypoxic cells in tumours with potential clinical applicability | Q36045083 | ||
| Binding of 14C-misonidazole to hypoxic cells in V79 spheroids | Q36046546 | ||
| Microscopic distribution of misonidazole in mouse tissues | Q36466982 | ||
| Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions | Q36467315 | ||
| Comparison between the binding of [3H]misonidazole and AF-2 in Chinese hamster V79 spheroids | Q36492299 | ||
| The use of fluorocarbon emulsions in cancer radiotherapy | Q37704002 | ||
| Hypoxic Sensitizers — Implications for Radiation Therapy | Q38039930 | ||
| Misonidazole and other hypoxia markers: metabolism and applications | Q39741419 | ||
| A novel technique for measuring human tissue pO2 at the cellular level | Q41146921 | ||
| Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo | Q41787769 | ||
| Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro | Q41839909 | ||
| Distribution of pimonidazole and RSU 1069 in tumour and normal tissues | Q41913928 | ||
| DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs? | Q42142796 | ||
| The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole | Q42253112 | ||
| A new mouse tumor model system (RIF-1) for comparison of end-point studies | Q42799818 | ||
| Is misonidazole binding to mouse tissues a measure of cellular pO2? | Q48194161 | ||
| Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography | Q48400674 | ||
| Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. | Q50545311 | ||
| Clinical trials with etanidazole (SR-2508) by the radiation therapy oncology group (RTOG) | Q67898813 | ||
| Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia | Q67958100 | ||
| Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse | Q68708575 | ||
| Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro | Q69395040 | ||
| Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T | Q69592519 | ||
| In vitro binding of 14C-misonidazole to hepatocytes and hepatoma cells | Q69592521 | ||
| Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia | Q69785312 | ||
| SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes | Q70142715 | ||
| Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice | Q70582887 | ||
| Pharmacology and toxicology of sensitizers: mechanism studies | Q70590155 | ||
| Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration | Q70590161 | ||
| Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells | Q71681059 | ||
| Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508 | Q72825375 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer research | Q3421914 |
| oncology | Q162555 | ||
| cell hypoxia | Q71228512 | ||
| P304 | page(s) | 1103-1108 | |
| P577 | publication date | 1992-12-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells | |
| P478 | volume | 66 |
| Q36116288 | Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption |
| Q38884487 | Biological characterization of novel nitroimidazole-peptide conjugates in vitro and in vivo |
| Q38177279 | Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling. |
| Q92654817 | Electron paramagnetic resonance oximetry as a novel approach to monitor the effectiveness and quality of red blood cell transfusions |
| Q58692404 | Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs |
| Q36081607 | Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver |
| Q45071084 | HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis |
| Q39002822 | Hypoxia: A Double-Edged Sword in Cancer Therapy |
| Q35928036 | In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment |
| Q33486397 | Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention |
| Q71993168 | Kinetic Analysis of Technetium-99m-Labeled Nitroimidazole (BMS-181321) as a Tracer of Myocardial Hypoxia |
| Q37242284 | Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. |
| Q35136222 | Prognostic significance of tumor oxygenation in humans. |
| Q33723814 | Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker? |
Search more.